Clear Street raised the firm’s price target on Krystal Biotech (KRYS) to $217 from $212 and keeps a Buy rating on the shares after Krystal ...
Investor's Business Daily on MSN
Stocks To Watch: Krystal Biotech Sees RS Rating Rise To 86
The Relative Strength (RS) Rating for Krystal Biotech KRYS entered a new percentile Tuesday, with a rise from 80 to 86. IBD's ...
Krystal Biotech (NASDAQ:KRYS – Free Report) had its price objective trimmed by Chardan Capital from $219.00 to $216.00 in a research note issued to investors on Friday,Benzinga reports. The firm ...
Detailed price information for Xenon Pharmaceuticals Inc (XENE-Q) from The Globe and Mail including charting and trades.
Krystal Biotech Inc. stock grades by Barron's. View KRYS fundamental and sentiment analysis powered by MarketGrader.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback